APA (7th ed.) Citation

Isenberg, D. A., Gordon, C., Dore, C. J., Caverly, E., Chowdhury, K., Jones, A., . . . Ehrenstein, M. R. Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: A prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Isenberg, David A., Caroline Gordon, Caroline J. Dore, Emilia Caverly, Kashfia Chowdhury, Alexis Jones, Patrick Muller, Felicia Ikeji, and Michael R. Ehrenstein. Belimumab After B Cell Depletion Therapy in Patients with Systemic Lupus Erythematosus (BEAT Lupus) Protocol: A Prospective Multicentre, Double-blind, Randomised, Placebo-controlled, 52-week Phase II Clinical Trial. BMJ Publishing Group.

MLA (9th ed.) Citation

Isenberg, David A., et al. Belimumab After B Cell Depletion Therapy in Patients with Systemic Lupus Erythematosus (BEAT Lupus) Protocol: A Prospective Multicentre, Double-blind, Randomised, Placebo-controlled, 52-week Phase II Clinical Trial. BMJ Publishing Group.